Clinical Trial: The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07507513) titled 'The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC' on March 26.

Brief Summary: This study will evaluate the efficacy and safety of 627 in patients with UC.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis (UC)

Intervention: DRUG: 627

627 subcutaneous (SC) injection.

DRUG: Placebo

Placebo subcutaneous (SC) injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Disclaimer: Curated by HT Syndication....